These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 38773976)
21. CD19 Zhang Y; Wang W; Liu Q; Jiang J; Zhao P; Huang C; Li Y; Fu Y Int Immunopharmacol; 2024 Nov; 141():113002. PubMed ID: 39213870 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer. Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494 [TBL] [Abstract][Full Text] [Related]
23. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients. Xin H; Chen Y; Niu H; Li X; Gai X; Cui G Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378 [TBL] [Abstract][Full Text] [Related]
24. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis. Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559 [TBL] [Abstract][Full Text] [Related]
25. Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential. Cao F; Liu Y; Cheng Y; Wang Y; He Y; Xu Y Sci Rep; 2023 Oct; 13(1):18265. PubMed ID: 37880233 [TBL] [Abstract][Full Text] [Related]
26. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X Front Immunol; 2021; 12():651033. PubMed ID: 34054812 [TBL] [Abstract][Full Text] [Related]
27. Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular production. Xia Y; Wang X; Lin J; Li Y; Dong L; Liang X; Wang HY; Ding X; Wang Q Front Immunol; 2024; 15():1375013. PubMed ID: 39040110 [TBL] [Abstract][Full Text] [Related]
28. PANoptosis subtypes predict prognosis and immune efficacy in gastric cancer. Liu Z; Sun L; Peng X; Zhu J; Wu C; Zhu W; Huang C; Zhu Z Apoptosis; 2024 Jun; 29(5-6):799-815. PubMed ID: 38347337 [TBL] [Abstract][Full Text] [Related]
29. NF- Chen Q; Du X; Hu S; Huang Q Biomed Res Int; 2022; 2022():5092505. PubMed ID: 35036435 [TBL] [Abstract][Full Text] [Related]
30. Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer. Xu L; Liu J; An Y; Zhou L; Sun H; Xu Z; Wang D; Liang Z; Xu C; Wang B; Li W BMC Cancer; 2024 Aug; 24(1):979. PubMed ID: 39118022 [TBL] [Abstract][Full Text] [Related]
31. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing. Li J; Han T; Wang X; Wang Y; Yang R; Yang Q Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299 [TBL] [Abstract][Full Text] [Related]
32. Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis. Xing X; Shi J; Jia Y; Dou Y; Li Z; Dong B; Guo T; Cheng X; Li X; Du H; Hu Y; Jia S; Zhang J; Li Z; Ji J J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35361730 [TBL] [Abstract][Full Text] [Related]
33. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer. Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y Front Immunol; 2022; 13():977338. PubMed ID: 36159818 [TBL] [Abstract][Full Text] [Related]
34. Cui M; Wang X; Qiao H; Wu S; Shang B Heliyon; 2024 Jul; 10(14):e34360. PubMed ID: 39130462 [TBL] [Abstract][Full Text] [Related]
35. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer. Chen T; Yang C; Dou R; Xiong B Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341 [TBL] [Abstract][Full Text] [Related]
36. Development and validation of a hypoxia- and mitochondrial dysfunction- related prognostic model based on integrated single-cell and bulk RNA sequencing analyses in gastric cancer. Li Y; Cui Y; Wang Z; Wang L; Yu Y; Xiong Y Front Immunol; 2024; 15():1419133. PubMed ID: 39165353 [TBL] [Abstract][Full Text] [Related]
37. Pyroptosis, apoptosis, and necroptosis molecular subtype derived prognostic signature universal applicable for gastric cancer-A large sample and multicenter retrospective analysis. Huo J; Xie W; Fan X; Sun P Comput Biol Med; 2022 Oct; 149():106037. PubMed ID: 36044785 [TBL] [Abstract][Full Text] [Related]
38. Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Breast Cancer. Wu J; Zhu Y; Luo M; Li L Front Immunol; 2021; 12():748221. PubMed ID: 34659246 [TBL] [Abstract][Full Text] [Related]
39. Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer. Wang J; Feng J; Chen X; Weng Y; Wang T; Wei J; Zhan Y; Peng M Aging (Albany NY); 2024 Apr; 16(8):7331-7356. PubMed ID: 38656888 [TBL] [Abstract][Full Text] [Related]
40. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer. Duan R; Li X; Zeng D; Chen X; Shen B; Zhu D; Zhu L; Yu Y; Wang D Front Immunol; 2020; 11():609337. PubMed ID: 33569057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]